nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—CYP11B1—Hydrocortisone—psoriasis	0.0853	0.121	CbGbCtD
Phenytoin—SLCO1C1—Methotrexate—psoriasis	0.0377	0.0536	CbGbCtD
Phenytoin—ALB—Acitretin—psoriasis	0.0357	0.0508	CbGbCtD
Phenytoin—CYP2C8—Tazarotene—psoriasis	0.0349	0.0497	CbGbCtD
Phenytoin—CYP3A5—Beclomethasone—psoriasis	0.0338	0.048	CbGbCtD
Phenytoin—ABCC2—Mycophenolate mofetil—psoriasis	0.0269	0.0382	CbGbCtD
Phenytoin—ABCC2—Cyclosporine—psoriasis	0.0203	0.0289	CbGbCtD
Phenytoin—CYP2B6—Cholecalciferol—psoriasis	0.0197	0.028	CbGbCtD
Phenytoin—ALB—Mycophenolate mofetil—psoriasis	0.0167	0.0238	CbGbCtD
Phenytoin—CYP2C8—Cholecalciferol—psoriasis	0.0149	0.0212	CbGbCtD
Phenytoin—CYP3A7—Hydrocortisone—psoriasis	0.0144	0.0205	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0144	0.0205	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0136	0.0193	CbGbCtD
Phenytoin—CYP3A7—Cyclosporine—psoriasis	0.0136	0.0193	CbGbCtD
Phenytoin—CYP3A5—Mycophenolate mofetil—psoriasis	0.0134	0.0191	CbGbCtD
Phenytoin—ABCC2—Dexamethasone—psoriasis	0.0134	0.0191	CbGbCtD
Phenytoin—ALB—Prednisone—psoriasis	0.0134	0.019	CbGbCtD
Phenytoin—CYP2C8—Mycophenolate mofetil—psoriasis	0.0129	0.0184	CbGbCtD
Phenytoin—CYP2C19—Cholecalciferol—psoriasis	0.0125	0.0178	CbGbCtD
Phenytoin—CYP3A4—Calcitriol—psoriasis	0.0117	0.0167	CbGbCtD
Phenytoin—CYP3A5—Hydrocortisone—psoriasis	0.0108	0.0153	CbGbCtD
Phenytoin—ABCC2—Methotrexate—psoriasis	0.0108	0.0153	CbGbCtD
Phenytoin—CYP2C9—Cholecalciferol—psoriasis	0.0104	0.0148	CbGbCtD
Phenytoin—CYP2C8—Hydrocortisone—psoriasis	0.0104	0.0148	CbGbCtD
Phenytoin—CYP3A5—Cyclosporine—psoriasis	0.0102	0.0145	CbGbCtD
Phenytoin—CYP2C8—Cyclosporine—psoriasis	0.0098	0.0139	CbGbCtD
Phenytoin—CYP3A4—Methoxsalen—psoriasis	0.00913	0.013	CbGbCtD
Phenytoin—CYP3A7—Dexamethasone—psoriasis	0.00895	0.0127	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00895	0.0127	CbGbCtD
Phenytoin—ABCB1—Mycophenolate mofetil—psoriasis	0.00875	0.0124	CbGbCtD
Phenytoin—CYP2C19—Prednisone—psoriasis	0.00867	0.0123	CbGbCtD
Phenytoin—CYP2B6—Dexamethasone—psoriasis	0.00852	0.0121	CbGbCtD
Phenytoin—CYP2C19—Cyclosporine—psoriasis	0.00822	0.0117	CbGbCtD
Phenytoin—ABCB1—Betamethasone—psoriasis	0.00751	0.0107	CbGbCtD
Phenytoin—ABCB1—Prednisolone—psoriasis	0.00741	0.0105	CbGbCtD
Phenytoin—ABCB1—Hydrocortisone—psoriasis	0.00702	0.00999	CbGbCtD
Phenytoin—ABCB1—Prednisone—psoriasis	0.007	0.00995	CbGbCtD
Phenytoin—CYP2C9—Cyclosporine—psoriasis	0.00684	0.00972	CbGbCtD
Phenytoin—CYP3A5—Dexamethasone—psoriasis	0.00671	0.00954	CbGbCtD
Phenytoin—ALB—Methotrexate—psoriasis	0.00671	0.00954	CbGbCtD
Phenytoin—ABCB1—Cyclosporine—psoriasis	0.00663	0.00943	CbGbCtD
Phenytoin—CYP2C8—Dexamethasone—psoriasis	0.00645	0.00917	CbGbCtD
Phenytoin—CYP3A4—Cholecalciferol—psoriasis	0.00605	0.0086	CbGbCtD
Phenytoin—CYP2C19—Dexamethasone—psoriasis	0.00541	0.0077	CbGbCtD
Phenytoin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00524	0.00746	CbGbCtD
Phenytoin—CYP3A4—Triamcinolone—psoriasis	0.00524	0.00746	CbGbCtD
Phenytoin—CYP2C9—Dexamethasone—psoriasis	0.0045	0.0064	CbGbCtD
Phenytoin—CYP3A4—Betamethasone—psoriasis	0.0045	0.0064	CbGbCtD
Phenytoin—CYP3A4—Prednisolone—psoriasis	0.00444	0.00631	CbGbCtD
Phenytoin—ABCB1—Dexamethasone—psoriasis	0.00437	0.00621	CbGbCtD
Phenytoin—CYP3A4—Hydrocortisone—psoriasis	0.00421	0.00598	CbGbCtD
Phenytoin—CYP3A4—Prednisone—psoriasis	0.00419	0.00596	CbGbCtD
Phenytoin—CYP3A4—Cyclosporine—psoriasis	0.00397	0.00565	CbGbCtD
Phenytoin—ABCB1—Methotrexate—psoriasis	0.00351	0.00499	CbGbCtD
Phenytoin—CYP3A4—Dexamethasone—psoriasis	0.00262	0.00372	CbGbCtD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—CP—psoriasis	0.000116	0.0028	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—CARM1—psoriasis	0.000116	0.00279	CbGpPWpGaD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000113	0.00272	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—CARM1—psoriasis	0.000111	0.00268	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—CARM1—psoriasis	0.000111	0.00268	CbGpPWpGaD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000111	0.00267	CbGpPWpGaD
Phenytoin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000111	0.00267	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—IL10—psoriasis	0.00011	0.00265	CbGpPWpGaD
Phenytoin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000109	0.00263	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—CARM1—psoriasis	0.000107	0.00258	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SERPINB8—psoriasis	0.000104	0.00251	CbGpPWpGaD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000101	0.00244	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000101	0.00243	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—IL13—psoriasis	0.0001	0.00241	CbGpPWpGaD
Phenytoin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	9.95e-05	0.0024	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—IL17A—psoriasis	9.22e-05	0.00222	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—NDUFA5—psoriasis	8.88e-05	0.00214	CbGpPWpGaD
Phenytoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.82e-05	0.00212	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—CAT—psoriasis	8.75e-05	0.00211	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—IL12B—psoriasis	8.57e-05	0.00206	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—CRP—psoriasis	8.54e-05	0.00206	CbGpPWpGaD
Phenytoin—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	8.49e-05	0.00204	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.37e-05	0.00202	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—APOE—psoriasis	8.35e-05	0.00201	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.28e-05	0.002	CbGpPWpGaD
Phenytoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.24e-05	0.00198	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—IL4—psoriasis	8.04e-05	0.00194	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.85e-05	0.00189	CbGpPWpGaD
Phenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.79e-05	0.00188	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—TYK2—psoriasis	7.64e-05	0.00184	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—CYP2S1—psoriasis	7.55e-05	0.00182	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—CARM1—psoriasis	7.53e-05	0.00181	CbGpPWpGaD
Phenytoin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.31e-05	0.00176	CbGpPWpGaD
Phenytoin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.2e-05	0.00174	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—LEP—psoriasis	7.15e-05	0.00172	CbGpPWpGaD
Phenytoin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7e-05	0.00169	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.95e-05	0.00167	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—CRP—psoriasis	6.94e-05	0.00167	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.92e-05	0.00167	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—NDUFA5—psoriasis	6.58e-05	0.00158	CbGpPWpGaD
Phenytoin—Anaphylactic shock—Triamcinolone—psoriasis	6.38e-05	0.00025	CcSEcCtD
Phenytoin—ALB—Folate Metabolism—ICAM1—psoriasis	6.38e-05	0.00154	CbGpPWpGaD
Phenytoin—Vertigo—Dexamethasone—psoriasis	6.38e-05	0.00025	CcSEcCtD
Phenytoin—Vertigo—Betamethasone—psoriasis	6.38e-05	0.00025	CcSEcCtD
Phenytoin—Syncope—Dexamethasone—psoriasis	6.36e-05	0.00025	CcSEcCtD
Phenytoin—Syncope—Betamethasone—psoriasis	6.36e-05	0.00025	CcSEcCtD
Phenytoin—Constipation—Mycophenolate mofetil—psoriasis	6.36e-05	0.00025	CcSEcCtD
Phenytoin—Infection—Triamcinolone—psoriasis	6.34e-05	0.000249	CcSEcCtD
Phenytoin—Sweating—Methotrexate—psoriasis	6.34e-05	0.000248	CcSEcCtD
Phenytoin—Hypotension—Hydrocortisone—psoriasis	6.34e-05	0.000248	CcSEcCtD
Phenytoin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.3e-05	0.00152	CbGpPWpGaD
Phenytoin—Feeling abnormal—Cyclosporine—psoriasis	6.29e-05	0.000246	CcSEcCtD
Phenytoin—Shock—Triamcinolone—psoriasis	6.28e-05	0.000246	CcSEcCtD
Phenytoin—Insomnia—Prednisolone—psoriasis	6.28e-05	0.000246	CcSEcCtD
Phenytoin—ABCB1—Allograft Rejection—IL10—psoriasis	6.27e-05	0.00151	CbGpPWpGaD
Phenytoin—Hepatobiliary disease—Methotrexate—psoriasis	6.25e-05	0.000245	CcSEcCtD
Phenytoin—Loss of consciousness—Dexamethasone—psoriasis	6.24e-05	0.000245	CcSEcCtD
Phenytoin—Loss of consciousness—Betamethasone—psoriasis	6.24e-05	0.000245	CcSEcCtD
Phenytoin—Dizziness—Mycophenolic acid—psoriasis	6.24e-05	0.000245	CcSEcCtD
Phenytoin—Epistaxis—Methotrexate—psoriasis	6.23e-05	0.000244	CcSEcCtD
Phenytoin—Paraesthesia—Prednisolone—psoriasis	6.23e-05	0.000244	CcSEcCtD
Phenytoin—Tachycardia—Triamcinolone—psoriasis	6.23e-05	0.000244	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—PPARG—psoriasis	6.22e-05	0.0015	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—TYK2—psoriasis	6.18e-05	0.00149	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	6.18e-05	0.000242	CcSEcCtD
Phenytoin—Hyperhidrosis—Triamcinolone—psoriasis	6.17e-05	0.000242	CcSEcCtD
Phenytoin—Agranulocytosis—Methotrexate—psoriasis	6.17e-05	0.000242	CcSEcCtD
Phenytoin—Convulsion—Betamethasone—psoriasis	6.15e-05	0.000241	CcSEcCtD
Phenytoin—Convulsion—Dexamethasone—psoriasis	6.15e-05	0.000241	CcSEcCtD
Phenytoin—Feeling abnormal—Mycophenolate mofetil—psoriasis	6.13e-05	0.00024	CcSEcCtD
Phenytoin—Insomnia—Hydrocortisone—psoriasis	6.13e-05	0.00024	CcSEcCtD
Phenytoin—Hypertension—Betamethasone—psoriasis	6.13e-05	0.00024	CcSEcCtD
Phenytoin—Hypertension—Dexamethasone—psoriasis	6.13e-05	0.00024	CcSEcCtD
Phenytoin—ABCB1—Allograft Rejection—IL4—psoriasis	6.1e-05	0.00147	CbGpPWpGaD
Phenytoin—Paraesthesia—Hydrocortisone—psoriasis	6.09e-05	0.000239	CcSEcCtD
Phenytoin—Urticaria—Cyclosporine—psoriasis	6.06e-05	0.000238	CcSEcCtD
Phenytoin—Myalgia—Dexamethasone—psoriasis	6.04e-05	0.000237	CcSEcCtD
Phenytoin—Myalgia—Betamethasone—psoriasis	6.04e-05	0.000237	CcSEcCtD
Phenytoin—Body temperature increased—Cyclosporine—psoriasis	6.03e-05	0.000236	CcSEcCtD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.02e-05	0.00145	CbGpPWpGaD
Phenytoin—Vomiting—Mycophenolic acid—psoriasis	6e-05	0.000235	CcSEcCtD
Phenytoin—Discomfort—Dexamethasone—psoriasis	5.97e-05	0.000234	CcSEcCtD
Phenytoin—Discomfort—Betamethasone—psoriasis	5.97e-05	0.000234	CcSEcCtD
Phenytoin—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.97e-05	0.00144	CbGpPWpGaD
Phenytoin—Dyspepsia—Hydrocortisone—psoriasis	5.97e-05	0.000234	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—psoriasis	5.96e-05	0.000234	CcSEcCtD
Phenytoin—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.96e-05	0.00144	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.95e-05	0.00143	CbGpPWpGaD
Phenytoin—Rash—Mycophenolic acid—psoriasis	5.95e-05	0.000233	CcSEcCtD
Phenytoin—Dermatitis—Mycophenolic acid—psoriasis	5.94e-05	0.000233	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—psoriasis	5.93e-05	0.000233	CcSEcCtD
Phenytoin—SCN3A—Axon guidance—TYK2—psoriasis	5.91e-05	0.00142	CbGpPWpGaD
Phenytoin—Urticaria—Mycophenolate mofetil—psoriasis	5.91e-05	0.000232	CcSEcCtD
Phenytoin—Headache—Mycophenolic acid—psoriasis	5.91e-05	0.000232	CcSEcCtD
Phenytoin—Decreased appetite—Hydrocortisone—psoriasis	5.89e-05	0.000231	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—psoriasis	5.89e-05	0.000231	CcSEcCtD
Phenytoin—Body temperature increased—Mycophenolate mofetil—psoriasis	5.88e-05	0.000231	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.85e-05	0.00023	CcSEcCtD
Phenytoin—Fatigue—Hydrocortisone—psoriasis	5.85e-05	0.000229	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Triamcinolone—psoriasis	5.82e-05	0.000228	CcSEcCtD
Phenytoin—Anaphylactic shock—Betamethasone—psoriasis	5.79e-05	0.000227	CcSEcCtD
Phenytoin—Anaphylactic shock—Dexamethasone—psoriasis	5.79e-05	0.000227	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—LEP—psoriasis	5.78e-05	0.00139	CbGpPWpGaD
Phenytoin—Insomnia—Triamcinolone—psoriasis	5.77e-05	0.000226	CcSEcCtD
Phenytoin—Infection—Betamethasone—psoriasis	5.75e-05	0.000226	CcSEcCtD
Phenytoin—Infection—Dexamethasone—psoriasis	5.75e-05	0.000226	CcSEcCtD
Phenytoin—Ill-defined disorder—Prednisone—psoriasis	5.73e-05	0.000225	CcSEcCtD
Phenytoin—Paraesthesia—Triamcinolone—psoriasis	5.73e-05	0.000225	CcSEcCtD
Phenytoin—Feeling abnormal—Prednisolone—psoriasis	5.72e-05	0.000224	CcSEcCtD
Phenytoin—Anaemia—Prednisone—psoriasis	5.71e-05	0.000224	CcSEcCtD
Phenytoin—Shock—Betamethasone—psoriasis	5.7e-05	0.000223	CcSEcCtD
Phenytoin—Shock—Dexamethasone—psoriasis	5.7e-05	0.000223	CcSEcCtD
Phenytoin—Dyspnoea—Triamcinolone—psoriasis	5.69e-05	0.000223	CcSEcCtD
Phenytoin—SCN4A—Axon guidance—TYK2—psoriasis	5.68e-05	0.00137	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—TYK2—psoriasis	5.68e-05	0.00137	CbGpPWpGaD
Phenytoin—Nervous system disorder—Dexamethasone—psoriasis	5.68e-05	0.000223	CcSEcCtD
Phenytoin—Nervous system disorder—Betamethasone—psoriasis	5.68e-05	0.000223	CcSEcCtD
Phenytoin—Agitation—Prednisone—psoriasis	5.68e-05	0.000223	CcSEcCtD
Phenytoin—Thrombocytopenia—Dexamethasone—psoriasis	5.67e-05	0.000222	CcSEcCtD
Phenytoin—Thrombocytopenia—Betamethasone—psoriasis	5.67e-05	0.000222	CcSEcCtD
Phenytoin—Tachycardia—Betamethasone—psoriasis	5.65e-05	0.000222	CcSEcCtD
Phenytoin—Tachycardia—Dexamethasone—psoriasis	5.65e-05	0.000222	CcSEcCtD
Phenytoin—Hypersensitivity—Cyclosporine—psoriasis	5.62e-05	0.00022	CcSEcCtD
Phenytoin—Dyspepsia—Triamcinolone—psoriasis	5.62e-05	0.00022	CcSEcCtD
Phenytoin—Erythema multiforme—Methotrexate—psoriasis	5.61e-05	0.00022	CcSEcCtD
Phenytoin—Nausea—Mycophenolic acid—psoriasis	5.6e-05	0.00022	CcSEcCtD
Phenytoin—Hyperhidrosis—Betamethasone—psoriasis	5.6e-05	0.00022	CcSEcCtD
Phenytoin—Hyperhidrosis—Dexamethasone—psoriasis	5.6e-05	0.00022	CcSEcCtD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—JUN—psoriasis	5.59e-05	0.00135	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CYP2S1—psoriasis	5.59e-05	0.00135	CbGpPWpGaD
Phenytoin—Feeling abnormal—Hydrocortisone—psoriasis	5.59e-05	0.000219	CcSEcCtD
Phenytoin—Malaise—Prednisone—psoriasis	5.57e-05	0.000219	CcSEcCtD
Phenytoin—Vertigo—Prednisone—psoriasis	5.55e-05	0.000218	CcSEcCtD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.55e-05	0.00134	CbGpPWpGaD
Phenytoin—Syncope—Prednisone—psoriasis	5.54e-05	0.000217	CcSEcCtD
Phenytoin—Tinnitus—Methotrexate—psoriasis	5.53e-05	0.000217	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—LEP—psoriasis	5.53e-05	0.00133	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.52e-05	0.00133	CbGpPWpGaD
Phenytoin—Anorexia—Betamethasone—psoriasis	5.52e-05	0.000216	CcSEcCtD
Phenytoin—Anorexia—Dexamethasone—psoriasis	5.52e-05	0.000216	CcSEcCtD
Phenytoin—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.52e-05	0.00133	CbGpPWpGaD
Phenytoin—Urticaria—Prednisolone—psoriasis	5.51e-05	0.000216	CcSEcCtD
Phenytoin—Fatigue—Triamcinolone—psoriasis	5.5e-05	0.000216	CcSEcCtD
Phenytoin—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.48e-05	0.000215	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—TYK2—psoriasis	5.48e-05	0.00132	CbGpPWpGaD
Phenytoin—Asthenia—Cyclosporine—psoriasis	5.47e-05	0.000215	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—TYK2—psoriasis	5.45e-05	0.00131	CbGpPWpGaD
Phenytoin—Loss of consciousness—Prednisone—psoriasis	5.43e-05	0.000213	CcSEcCtD
Phenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.43e-05	0.00131	CbGpPWpGaD
Phenytoin—Hypotension—Dexamethasone—psoriasis	5.41e-05	0.000212	CcSEcCtD
Phenytoin—Hypotension—Betamethasone—psoriasis	5.41e-05	0.000212	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—VEGFA—psoriasis	5.41e-05	0.0013	CbGpPWpGaD
Phenytoin—Pruritus—Cyclosporine—psoriasis	5.4e-05	0.000212	CcSEcCtD
Phenytoin—Urticaria—Hydrocortisone—psoriasis	5.39e-05	0.000211	CcSEcCtD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.38e-05	0.0013	CbGpPWpGaD
Phenytoin—Immune system disorder—Methotrexate—psoriasis	5.36e-05	0.00021	CcSEcCtD
Phenytoin—Body temperature increased—Hydrocortisone—psoriasis	5.36e-05	0.00021	CcSEcCtD
Phenytoin—Convulsion—Prednisone—psoriasis	5.36e-05	0.00021	CcSEcCtD
Phenytoin—Asthenia—Mycophenolate mofetil—psoriasis	5.34e-05	0.000209	CcSEcCtD
Phenytoin—Hypertension—Prednisone—psoriasis	5.34e-05	0.000209	CcSEcCtD
Phenytoin—Chills—Methotrexate—psoriasis	5.32e-05	0.000209	CcSEcCtD
Phenytoin—SCN4A—Developmental Biology—LEP—psoriasis	5.31e-05	0.00128	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—LEP—psoriasis	5.31e-05	0.00128	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.28e-05	0.000207	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Betamethasone—psoriasis	5.28e-05	0.000207	CcSEcCtD
Phenytoin—Pruritus—Mycophenolate mofetil—psoriasis	5.27e-05	0.000206	CcSEcCtD
Phenytoin—Myalgia—Prednisone—psoriasis	5.26e-05	0.000206	CcSEcCtD
Phenytoin—Arthralgia—Prednisone—psoriasis	5.26e-05	0.000206	CcSEcCtD
Phenytoin—Feeling abnormal—Triamcinolone—psoriasis	5.26e-05	0.000206	CcSEcCtD
Phenytoin—Insomnia—Betamethasone—psoriasis	5.24e-05	0.000205	CcSEcCtD
Phenytoin—Insomnia—Dexamethasone—psoriasis	5.24e-05	0.000205	CcSEcCtD
Phenytoin—Diarrhoea—Cyclosporine—psoriasis	5.22e-05	0.000205	CcSEcCtD
Phenytoin—Paraesthesia—Betamethasone—psoriasis	5.2e-05	0.000204	CcSEcCtD
Phenytoin—Paraesthesia—Dexamethasone—psoriasis	5.2e-05	0.000204	CcSEcCtD
Phenytoin—Discomfort—Prednisone—psoriasis	5.2e-05	0.000204	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—LEP—psoriasis	5.12e-05	0.00123	CbGpPWpGaD
Phenytoin—Hypersensitivity—Prednisolone—psoriasis	5.11e-05	0.000201	CcSEcCtD
Phenytoin—Dyspepsia—Dexamethasone—psoriasis	5.1e-05	0.0002	CcSEcCtD
Phenytoin—Dyspepsia—Betamethasone—psoriasis	5.1e-05	0.0002	CcSEcCtD
Phenytoin—Diarrhoea—Mycophenolate mofetil—psoriasis	5.09e-05	0.0002	CcSEcCtD
Phenytoin—Urticaria—Triamcinolone—psoriasis	5.07e-05	0.000199	CcSEcCtD
Phenytoin—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	5.07e-05	0.00122	CbGpPWpGaD
Phenytoin—Dysgeusia—Methotrexate—psoriasis	5.06e-05	0.000198	CcSEcCtD
Phenytoin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.05e-05	0.00122	CbGpPWpGaD
Phenytoin—Body temperature increased—Triamcinolone—psoriasis	5.05e-05	0.000198	CcSEcCtD
Phenytoin—Dizziness—Cyclosporine—psoriasis	5.04e-05	0.000198	CcSEcCtD
Phenytoin—Anaphylactic shock—Prednisone—psoriasis	5.04e-05	0.000198	CcSEcCtD
Phenytoin—Decreased appetite—Betamethasone—psoriasis	5.04e-05	0.000197	CcSEcCtD
Phenytoin—Decreased appetite—Dexamethasone—psoriasis	5.04e-05	0.000197	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—PPARG—psoriasis	5.03e-05	0.00121	CbGpPWpGaD
Phenytoin—Infection—Prednisone—psoriasis	5.01e-05	0.000196	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Dexamethasone—psoriasis	5e-05	0.000196	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Betamethasone—psoriasis	5e-05	0.000196	CcSEcCtD
Phenytoin—Back pain—Methotrexate—psoriasis	5e-05	0.000196	CcSEcCtD
Phenytoin—Hypersensitivity—Hydrocortisone—psoriasis	5e-05	0.000196	CcSEcCtD
Phenytoin—Fatigue—Dexamethasone—psoriasis	4.99e-05	0.000196	CcSEcCtD
Phenytoin—Fatigue—Betamethasone—psoriasis	4.99e-05	0.000196	CcSEcCtD
Phenytoin—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.98e-05	0.0012	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.97e-05	0.0012	CbGpPWpGaD
Phenytoin—Shock—Prednisone—psoriasis	4.96e-05	0.000195	CcSEcCtD
Phenytoin—Nervous system disorder—Prednisone—psoriasis	4.95e-05	0.000194	CcSEcCtD
Phenytoin—Tachycardia—Prednisone—psoriasis	4.92e-05	0.000193	CcSEcCtD
Phenytoin—Dizziness—Mycophenolate mofetil—psoriasis	4.92e-05	0.000193	CcSEcCtD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.89e-05	0.00118	CbGpPWpGaD
Phenytoin—Hyperhidrosis—Prednisone—psoriasis	4.88e-05	0.000191	CcSEcCtD
Phenytoin—Asthenia—Hydrocortisone—psoriasis	4.86e-05	0.000191	CcSEcCtD
Phenytoin—ALB—Folate Metabolism—IFNG—psoriasis	4.86e-05	0.00117	CbGpPWpGaD
Phenytoin—Vomiting—Cyclosporine—psoriasis	4.85e-05	0.00019	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—PPARG—psoriasis	4.82e-05	0.00116	CbGpPWpGaD
Phenytoin—Rash—Cyclosporine—psoriasis	4.81e-05	0.000189	CcSEcCtD
Phenytoin—Anorexia—Prednisone—psoriasis	4.81e-05	0.000189	CcSEcCtD
Phenytoin—Dermatitis—Cyclosporine—psoriasis	4.81e-05	0.000188	CcSEcCtD
Phenytoin—Pruritus—Hydrocortisone—psoriasis	4.8e-05	0.000188	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—psoriasis	4.79e-05	0.000188	CcSEcCtD
Phenytoin—Headache—Cyclosporine—psoriasis	4.78e-05	0.000187	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—psoriasis	4.77e-05	0.000187	CcSEcCtD
Phenytoin—Feeling abnormal—Betamethasone—psoriasis	4.77e-05	0.000187	CcSEcCtD
Phenytoin—Feeling abnormal—Dexamethasone—psoriasis	4.77e-05	0.000187	CcSEcCtD
Phenytoin—Vomiting—Mycophenolate mofetil—psoriasis	4.73e-05	0.000186	CcSEcCtD
Phenytoin—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	4.71e-05	0.00114	CbGpPWpGaD
Phenytoin—Hypersensitivity—Triamcinolone—psoriasis	4.7e-05	0.000184	CcSEcCtD
Phenytoin—Rash—Mycophenolate mofetil—psoriasis	4.69e-05	0.000184	CcSEcCtD
Phenytoin—Dermatitis—Mycophenolate mofetil—psoriasis	4.69e-05	0.000184	CcSEcCtD
Phenytoin—Headache—Mycophenolate mofetil—psoriasis	4.66e-05	0.000183	CcSEcCtD
Phenytoin—Malaise—Methotrexate—psoriasis	4.66e-05	0.000183	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—psoriasis	4.64e-05	0.000182	CcSEcCtD
Phenytoin—Diarrhoea—Hydrocortisone—psoriasis	4.64e-05	0.000182	CcSEcCtD
Phenytoin—SCN2A—Developmental Biology—PPARG—psoriasis	4.63e-05	0.00111	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—PPARG—psoriasis	4.63e-05	0.00111	CbGpPWpGaD
Phenytoin—Leukopenia—Methotrexate—psoriasis	4.62e-05	0.000181	CcSEcCtD
Phenytoin—Urticaria—Betamethasone—psoriasis	4.6e-05	0.00018	CcSEcCtD
Phenytoin—Urticaria—Dexamethasone—psoriasis	4.6e-05	0.00018	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Prednisone—psoriasis	4.6e-05	0.00018	CcSEcCtD
Phenytoin—Dizziness—Prednisolone—psoriasis	4.59e-05	0.00018	CcSEcCtD
Phenytoin—Asthenia—Triamcinolone—psoriasis	4.58e-05	0.00018	CcSEcCtD
Phenytoin—Body temperature increased—Betamethasone—psoriasis	4.58e-05	0.00018	CcSEcCtD
Phenytoin—Body temperature increased—Dexamethasone—psoriasis	4.58e-05	0.00018	CcSEcCtD
Phenytoin—Insomnia—Prednisone—psoriasis	4.56e-05	0.000179	CcSEcCtD
Phenytoin—Nausea—Cyclosporine—psoriasis	4.53e-05	0.000178	CcSEcCtD
Phenytoin—Paraesthesia—Prednisone—psoriasis	4.53e-05	0.000178	CcSEcCtD
Phenytoin—Pruritus—Triamcinolone—psoriasis	4.52e-05	0.000177	CcSEcCtD
Phenytoin—Cough—Methotrexate—psoriasis	4.51e-05	0.000177	CcSEcCtD
Phenytoin—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	4.5e-05	0.00108	CbGpPWpGaD
Phenytoin—Dizziness—Hydrocortisone—psoriasis	4.48e-05	0.000176	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—psoriasis	4.48e-05	0.000175	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—PPARG—psoriasis	4.46e-05	0.00107	CbGpPWpGaD
Phenytoin—Dyspepsia—Prednisone—psoriasis	4.44e-05	0.000174	CcSEcCtD
Phenytoin—Nausea—Mycophenolate mofetil—psoriasis	4.42e-05	0.000173	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—TYK2—psoriasis	4.41e-05	0.00106	CbGpPWpGaD
Phenytoin—Myalgia—Methotrexate—psoriasis	4.4e-05	0.000172	CcSEcCtD
Phenytoin—Arthralgia—Methotrexate—psoriasis	4.4e-05	0.000172	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—psoriasis	4.4e-05	0.000172	CcSEcCtD
Phenytoin—Decreased appetite—Prednisone—psoriasis	4.39e-05	0.000172	CcSEcCtD
Phenytoin—Rash—Prednisolone—psoriasis	4.38e-05	0.000172	CcSEcCtD
Phenytoin—Dermatitis—Prednisolone—psoriasis	4.37e-05	0.000171	CcSEcCtD
Phenytoin—CYP3A7—Metabolism—NDUFA5—psoriasis	4.37e-05	0.00105	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—VEGFA—psoriasis	4.37e-05	0.00105	CbGpPWpGaD
Phenytoin—Fatigue—Prednisone—psoriasis	4.35e-05	0.000171	CcSEcCtD
Phenytoin—Headache—Prednisolone—psoriasis	4.35e-05	0.000171	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—psoriasis	4.35e-05	0.00017	CcSEcCtD
Phenytoin—Constipation—Prednisone—psoriasis	4.31e-05	0.000169	CcSEcCtD
Phenytoin—Vomiting—Hydrocortisone—psoriasis	4.31e-05	0.000169	CcSEcCtD
Phenytoin—Rash—Hydrocortisone—psoriasis	4.27e-05	0.000168	CcSEcCtD
Phenytoin—Dermatitis—Hydrocortisone—psoriasis	4.27e-05	0.000167	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—psoriasis	4.25e-05	0.000167	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—NFKB1—psoriasis	4.25e-05	0.00102	CbGpPWpGaD
Phenytoin—Headache—Hydrocortisone—psoriasis	4.25e-05	0.000167	CcSEcCtD
Phenytoin—Dizziness—Triamcinolone—psoriasis	4.22e-05	0.000166	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—TYK2—psoriasis	4.22e-05	0.00102	CbGpPWpGaD
Phenytoin—Anaphylactic shock—Methotrexate—psoriasis	4.22e-05	0.000165	CcSEcCtD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—TNF—psoriasis	4.19e-05	0.00101	CbGpPWpGaD
Phenytoin—Infection—Methotrexate—psoriasis	4.19e-05	0.000164	CcSEcCtD
Phenytoin—SCN3A—Axon guidance—VEGFA—psoriasis	4.18e-05	0.00101	CbGpPWpGaD
Phenytoin—Feeling abnormal—Prednisone—psoriasis	4.16e-05	0.000163	CcSEcCtD
Phenytoin—Asthenia—Betamethasone—psoriasis	4.16e-05	0.000163	CcSEcCtD
Phenytoin—Asthenia—Dexamethasone—psoriasis	4.16e-05	0.000163	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—psoriasis	4.13e-05	0.000162	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—psoriasis	4.13e-05	0.000162	CcSEcCtD
Phenytoin—Nausea—Prednisolone—psoriasis	4.12e-05	0.000162	CcSEcCtD
Phenytoin—Pruritus—Dexamethasone—psoriasis	4.1e-05	0.000161	CcSEcCtD
Phenytoin—Pruritus—Betamethasone—psoriasis	4.1e-05	0.000161	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—psoriasis	4.08e-05	0.00016	CcSEcCtD
Phenytoin—Vomiting—Triamcinolone—psoriasis	4.06e-05	0.000159	CcSEcCtD
Phenytoin—SCN2A—Developmental Biology—TYK2—psoriasis	4.05e-05	0.000977	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—TYK2—psoriasis	4.05e-05	0.000977	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—NFKB1—psoriasis	4.04e-05	0.000974	CbGpPWpGaD
Phenytoin—Nausea—Hydrocortisone—psoriasis	4.03e-05	0.000158	CcSEcCtD
Phenytoin—Rash—Triamcinolone—psoriasis	4.03e-05	0.000158	CcSEcCtD
Phenytoin—Dermatitis—Triamcinolone—psoriasis	4.02e-05	0.000158	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—psoriasis	4.02e-05	0.000158	CcSEcCtD
Phenytoin—SCN4A—Axon guidance—VEGFA—psoriasis	4.02e-05	0.000968	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—VEGFA—psoriasis	4.02e-05	0.000968	CbGpPWpGaD
Phenytoin—Urticaria—Prednisone—psoriasis	4.01e-05	0.000157	CcSEcCtD
Phenytoin—Headache—Triamcinolone—psoriasis	4e-05	0.000157	CcSEcCtD
Phenytoin—Body temperature increased—Prednisone—psoriasis	3.99e-05	0.000156	CcSEcCtD
Phenytoin—Diarrhoea—Betamethasone—psoriasis	3.96e-05	0.000155	CcSEcCtD
Phenytoin—Diarrhoea—Dexamethasone—psoriasis	3.96e-05	0.000155	CcSEcCtD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.96e-05	0.000954	CbGpPWpGaD
Phenytoin—Hypotension—Methotrexate—psoriasis	3.94e-05	0.000154	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—TYK2—psoriasis	3.91e-05	0.000942	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—VEGFA—psoriasis	3.87e-05	0.000933	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.86e-05	0.000931	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.86e-05	0.000929	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—VEGFA—psoriasis	3.86e-05	0.000929	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—TYK2—psoriasis	3.85e-05	0.000928	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Methotrexate—psoriasis	3.84e-05	0.000151	CcSEcCtD
Phenytoin—Dizziness—Dexamethasone—psoriasis	3.83e-05	0.00015	CcSEcCtD
Phenytoin—Dizziness—Betamethasone—psoriasis	3.83e-05	0.00015	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—STAT3—psoriasis	3.82e-05	0.00092	CbGpPWpGaD
Phenytoin—Insomnia—Methotrexate—psoriasis	3.81e-05	0.00015	CcSEcCtD
Phenytoin—Nausea—Triamcinolone—psoriasis	3.79e-05	0.000149	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—psoriasis	3.79e-05	0.000148	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—psoriasis	3.76e-05	0.000147	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—psoriasis	3.75e-05	0.000147	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—IL6—psoriasis	3.74e-05	0.000901	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CYP2S1—psoriasis	3.72e-05	0.000895	CbGpPWpGaD
Phenytoin—Hypersensitivity—Prednisone—psoriasis	3.72e-05	0.000146	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—psoriasis	3.71e-05	0.000146	CcSEcCtD
Phenytoin—CYP11B1—Metabolism—CARM1—psoriasis	3.69e-05	0.000889	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—IFNG—psoriasis	3.69e-05	0.000888	CbGpPWpGaD
Phenytoin—Vomiting—Dexamethasone—psoriasis	3.68e-05	0.000144	CcSEcCtD
Phenytoin—Vomiting—Betamethasone—psoriasis	3.68e-05	0.000144	CcSEcCtD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.68e-05	0.000886	CbGpPWpGaD
Phenytoin—Decreased appetite—Methotrexate—psoriasis	3.66e-05	0.000144	CcSEcCtD
Phenytoin—Rash—Betamethasone—psoriasis	3.65e-05	0.000143	CcSEcCtD
Phenytoin—Rash—Dexamethasone—psoriasis	3.65e-05	0.000143	CcSEcCtD
Phenytoin—Dermatitis—Dexamethasone—psoriasis	3.65e-05	0.000143	CcSEcCtD
Phenytoin—Dermatitis—Betamethasone—psoriasis	3.65e-05	0.000143	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—psoriasis	3.64e-05	0.000143	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—psoriasis	3.63e-05	0.000143	CcSEcCtD
Phenytoin—Headache—Dexamethasone—psoriasis	3.63e-05	0.000142	CcSEcCtD
Phenytoin—Headache—Betamethasone—psoriasis	3.63e-05	0.000142	CcSEcCtD
Phenytoin—Asthenia—Prednisone—psoriasis	3.62e-05	0.000142	CcSEcCtD
Phenytoin—SCN5A—Developmental Biology—LEP—psoriasis	3.6e-05	0.000867	CbGpPWpGaD
Phenytoin—Pruritus—Prednisone—psoriasis	3.57e-05	0.00014	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—psoriasis	3.47e-05	0.000136	CcSEcCtD
Phenytoin—Diarrhoea—Prednisone—psoriasis	3.45e-05	0.000135	CcSEcCtD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.45e-05	0.000831	CbGpPWpGaD
Phenytoin—Nausea—Dexamethasone—psoriasis	3.44e-05	0.000135	CcSEcCtD
Phenytoin—Nausea—Betamethasone—psoriasis	3.44e-05	0.000135	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—NFKB1—psoriasis	3.44e-05	0.000828	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.43e-05	0.000826	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—IL6—psoriasis	3.38e-05	0.000814	CbGpPWpGaD
Phenytoin—Urticaria—Methotrexate—psoriasis	3.35e-05	0.000131	CcSEcCtD
Phenytoin—Dizziness—Prednisone—psoriasis	3.34e-05	0.000131	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—psoriasis	3.33e-05	0.000131	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—TNF—psoriasis	3.31e-05	0.000796	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—NFKB1—psoriasis	3.29e-05	0.000792	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NDUFA5—psoriasis	3.23e-05	0.000779	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.21e-05	0.000774	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	3.21e-05	0.000773	CbGpPWpGaD
Phenytoin—Vomiting—Prednisone—psoriasis	3.21e-05	0.000126	CcSEcCtD
Phenytoin—Rash—Prednisone—psoriasis	3.18e-05	0.000125	CcSEcCtD
Phenytoin—Dermatitis—Prednisone—psoriasis	3.18e-05	0.000125	CcSEcCtD
Phenytoin—CYP3A5—Metabolism—NDUFA5—psoriasis	3.16e-05	0.000761	CbGpPWpGaD
Phenytoin—Headache—Prednisone—psoriasis	3.16e-05	0.000124	CcSEcCtD
Phenytoin—SCN2A—Developmental Biology—NFKB1—psoriasis	3.16e-05	0.000761	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—NFKB1—psoriasis	3.16e-05	0.000761	CbGpPWpGaD
Phenytoin—ALB—Platelet degranulation—VEGFA—psoriasis	3.14e-05	0.000758	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TNF—psoriasis	3.14e-05	0.000757	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—PPARG—psoriasis	3.14e-05	0.000755	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—VEGFA—psoriasis	3.12e-05	0.000751	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—IL6—psoriasis	3.12e-05	0.000751	CbGpPWpGaD
Phenytoin—Hypersensitivity—Methotrexate—psoriasis	3.11e-05	0.000122	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—STAT3—psoriasis	3.09e-05	0.000744	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—NFKB1—psoriasis	3.05e-05	0.000734	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—ITGAL—psoriasis	3.03e-05	0.000729	CbGpPWpGaD
Phenytoin—Asthenia—Methotrexate—psoriasis	3.02e-05	0.000119	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—IL6—psoriasis	3.02e-05	0.000728	CbGpPWpGaD
Phenytoin—Nausea—Prednisone—psoriasis	3e-05	0.000117	CcSEcCtD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	3e-05	0.000722	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—VEGFA—psoriasis	2.98e-05	0.000719	CbGpPWpGaD
Phenytoin—Pruritus—Methotrexate—psoriasis	2.98e-05	0.000117	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—STAT3—psoriasis	2.95e-05	0.000712	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—IL6—psoriasis	2.89e-05	0.000697	CbGpPWpGaD
Phenytoin—Diarrhoea—Methotrexate—psoriasis	2.88e-05	0.000113	CcSEcCtD
Phenytoin—SCN4A—Developmental Biology—VEGFA—psoriasis	2.87e-05	0.000691	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—VEGFA—psoriasis	2.87e-05	0.000691	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—STAT3—psoriasis	2.84e-05	0.000684	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—STAT3—psoriasis	2.84e-05	0.000684	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.82e-05	0.00068	CbGpPWpGaD
Phenytoin—Dizziness—Methotrexate—psoriasis	2.79e-05	0.000109	CcSEcCtD
Phenytoin—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.78e-05	0.00067	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—IL6—psoriasis	2.78e-05	0.000669	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—IL6—psoriasis	2.78e-05	0.000669	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TP53—psoriasis	2.77e-05	0.000668	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—VEGFA—psoriasis	2.76e-05	0.000666	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP2S1—psoriasis	2.75e-05	0.000662	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—TYK2—psoriasis	2.75e-05	0.000662	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NDUFA5—psoriasis	2.74e-05	0.000659	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—STAT3—psoriasis	2.74e-05	0.000659	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CARM1—psoriasis	2.73e-05	0.000658	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—VEGFA—psoriasis	2.72e-05	0.000656	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NDUFA5—psoriasis	2.72e-05	0.000656	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP2S1—psoriasis	2.69e-05	0.000647	CbGpPWpGaD
Phenytoin—Vomiting—Methotrexate—psoriasis	2.68e-05	0.000105	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—IL6—psoriasis	2.68e-05	0.000645	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—TNF—psoriasis	2.67e-05	0.000644	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—IL6—psoriasis	2.67e-05	0.000643	CbGpPWpGaD
Phenytoin—Rash—Methotrexate—psoriasis	2.66e-05	0.000104	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—psoriasis	2.66e-05	0.000104	CcSEcCtD
Phenytoin—Headache—Methotrexate—psoriasis	2.64e-05	0.000104	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—TNF—psoriasis	2.56e-05	0.000616	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.55e-05	0.000615	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.54e-05	0.000611	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—IL6—psoriasis	2.54e-05	0.000611	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.53e-05	0.000609	CbGpPWpGaD
Phenytoin—Nausea—Methotrexate—psoriasis	2.5e-05	9.82e-05	CcSEcCtD
Phenytoin—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.5e-05	0.000602	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—TNF—psoriasis	2.46e-05	0.000592	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—TNF—psoriasis	2.46e-05	0.000592	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NDUFA5—psoriasis	2.44e-05	0.000589	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.41e-05	0.000581	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—TNF—psoriasis	2.39e-05	0.000575	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NDUFA5—psoriasis	2.38e-05	0.000574	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.37e-05	0.000571	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—TNF—psoriasis	2.37e-05	0.000571	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP2S1—psoriasis	2.33e-05	0.000561	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP2S1—psoriasis	2.31e-05	0.000557	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.28e-05	0.000549	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—CAT—psoriasis	2.27e-05	0.000547	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NDUFA5—psoriasis	2.23e-05	0.000537	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.22e-05	0.000534	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—IL6—psoriasis	2.16e-05	0.00052	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—NFKB1—psoriasis	2.14e-05	0.000516	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.11e-05	0.000509	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP2S1—psoriasis	2.08e-05	0.0005	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.08e-05	0.0005	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—IL6—psoriasis	2.06e-05	0.000497	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP2S1—psoriasis	2.03e-05	0.000488	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—IL6—psoriasis	2.02e-05	0.000485	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—IL6—psoriasis	1.98e-05	0.000478	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—IL6—psoriasis	1.98e-05	0.000478	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—VEGFA—psoriasis	1.94e-05	0.000468	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—STAT3—psoriasis	1.92e-05	0.000464	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—IL6—psoriasis	1.91e-05	0.000461	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP2S1—psoriasis	1.89e-05	0.000456	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—IL6—psoriasis	1.88e-05	0.000454	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CARM1—psoriasis	1.82e-05	0.000437	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—APOE—psoriasis	1.76e-05	0.000425	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CAT—psoriasis	1.68e-05	0.000405	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—TNF—psoriasis	1.67e-05	0.000401	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.57e-05	0.000379	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PPARG—psoriasis	1.54e-05	0.00037	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.51e-05	0.000365	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.47e-05	0.000354	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.39e-05	0.000336	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.37e-05	0.000331	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—IL6—psoriasis	1.34e-05	0.000324	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CARM1—psoriasis	1.34e-05	0.000323	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CARM1—psoriasis	1.31e-05	0.000316	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—APOE—psoriasis	1.31e-05	0.000314	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.25e-05	0.000301	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NOS2—psoriasis	1.24e-05	0.000299	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.000294	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.21e-05	0.000292	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.18e-05	0.000284	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PPARG—psoriasis	1.14e-05	0.000274	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CARM1—psoriasis	1.14e-05	0.000274	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CARM1—psoriasis	1.13e-05	0.000272	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CAT—psoriasis	1.12e-05	0.000269	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.09e-05	0.000262	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.000256	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.000254	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.04e-05	0.00025	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CARM1—psoriasis	1.01e-05	0.000244	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.93e-06	0.000239	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CARM1—psoriasis	9.9e-06	0.000239	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.48e-06	0.000228	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CARM1—psoriasis	9.25e-06	0.000223	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—APOE—psoriasis	8.68e-06	0.000209	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.65e-06	0.000208	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CAT—psoriasis	8.26e-06	0.000199	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CAT—psoriasis	8.07e-06	0.000194	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PPARG—psoriasis	7.56e-06	0.000182	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFA—psoriasis	7.19e-06	0.000173	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CAT—psoriasis	6.99e-06	0.000168	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CAT—psoriasis	6.95e-06	0.000167	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—APOE—psoriasis	6.42e-06	0.000155	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—APOE—psoriasis	6.27e-06	0.000151	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CAT—psoriasis	6.24e-06	0.00015	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CARM1—psoriasis	6.1e-06	0.000147	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CAT—psoriasis	6.09e-06	0.000147	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CAT—psoriasis	5.69e-06	0.000137	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PPARG—psoriasis	5.59e-06	0.000135	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PPARG—psoriasis	5.46e-06	0.000132	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—psoriasis	5.43e-06	0.000131	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—APOE—psoriasis	5.43e-06	0.000131	CbGpPWpGaD
Phenytoin—ALB—Metabolism—APOE—psoriasis	5.4e-06	0.00013	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—APOE—psoriasis	4.85e-06	0.000117	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—APOE—psoriasis	4.73e-06	0.000114	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PPARG—psoriasis	4.73e-06	0.000114	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PPARG—psoriasis	4.7e-06	0.000113	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—APOE—psoriasis	4.42e-06	0.000106	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PPARG—psoriasis	4.22e-06	0.000102	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PPARG—psoriasis	4.12e-06	9.93e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PPARG—psoriasis	3.85e-06	9.28e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CAT—psoriasis	3.75e-06	9.04e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—APOE—psoriasis	2.92e-06	7.02e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPARG—psoriasis	2.54e-06	6.12e-05	CbGpPWpGaD
